SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001204459-11-000421
Filing Date
2011-02-14
Accepted
2011-02-14 16:20:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A sch13ga_alnylam.htm SC 13G/A 37866
  Complete submission text file 0001204459-11-000421.txt   39854
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Subject) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79884 | Film No.: 11607545
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 WILSHIRE BOULEVARD SUITE 960 SANTA MONICA CA 90401
Business Address 100 WILSHIRE BOULEVARD SUITE 960 SANTA MONICA CA 90401 310-899-0800
Aletheia Research & Management, Inc. (Filed by) CIK: 0001302506 (see all company filings)

IRS No.: 954647814 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A